State FL
Clinical Trials in Florida
Florida is home to a significant concentration of clinical research activity, with academic medical centers, community hospitals, and specialized research clinics serving as active trial sites across a broad range of medical conditions. The studies listed here have at least one enrolled site in Florida and represent Phase 1 through Phase 4 research sponsored by NIH, pharmaceutical companies, device manufacturers, and independent investigators.
All trial data is sourced directly from ClinicalTrials.gov and updated daily. Recruiting status, eligibility criteria, enrollment targets, and contact information are included for each study. Patients and caregivers should review the full eligibility criteria on each trial listing — or consult their treating physician — before contacting a study site.
Top Conditions in Florida
Frequently Asked Questions — Clinical Trials in Florida
How many clinical trials are currently recruiting in Florida?
ClinicalMetric currently tracks 581 actively recruiting clinical trials with at least one location in Florida. The total number of registered studies—including active but not currently enrolling trials—is 581. Trial availability is updated daily from ClinicalTrials.gov, and new studies open enrollment regularly throughout the year.
What types of clinical trials are available in Florida?
Florida hosts clinical trials across a broad range of medical conditions, including Prostate Cancer, Colorectal Cancer, Advanced Solid Tumor, and many others. Trials range from Phase 1 early-safety studies to Phase 4 post-approval surveillance, as well as observational and behavioral research. Academic medical centers, community hospitals, and specialized research clinics throughout Florida serve as trial sites for studies sponsored by NIH, pharmaceutical companies, and independent investigators.
How do I join a clinical trial near me in Florida?
To join a clinical trial in Florida, browse the recruiting studies listed on this page, review the eligibility criteria for each trial, and contact the study site directly. Your primary care physician or specialist can also refer you to clinical trials relevant to your diagnosis. Many academic medical centers in Florida maintain dedicated clinical trials offices that can match you with appropriate studies based on your medical profile and diagnosis.
Recruiting Trials in Florida
NCT05647265 Phase 2
Recruiting
Testing the Addition of Immunotherapy Before Surgery for Patients With Sarcomato...
Condition
Pleural Biphasic Mesothelioma
Enrollment
26 pts
Location
United States
Sponsor
Alliance for Clinical Trials i
NCT05504707 Phase 1
Recruiting
DecipHER Trial - DC1 Tx for Early-Stage TNBC and ER Low Positive Breast Cancer
Condition
Triple Negative Breast Cancer
Enrollment
30 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT07535034 Phase 2
Recruiting
A Phase 2 Trial of Dotinurad in Xanthine Oxidase Inhibitor (XOI) Intolerant/Uric...
Condition
Gout
Enrollment
90 pts
Location
United States
Sponsor
Crystalys Therapeutics
NCT03016819 Phase 3
Recruiting
Phase III Trial of Anlotinib, Catequentinib in Advanced Alveolar Soft Part Sarco...
Condition
Alveolar Soft Part Sarcoma
Enrollment
325 pts
Location
United States, China, Italy
Sponsor
Advenchen Laboratories, LLC
NCT06237452 Phase 3
Recruiting
VE303 for Prevention of Recurrent Clostridioides Difficile Infection
Condition
Clostridium Difficile
Enrollment
852 pts
Location
United States, Australia, Belgium
Sponsor
Vedanta Biosciences, Inc.
NCT06426628 N/A
Recruiting
Clinical Utility of Management of Patients With Pulmonary Nodules Using the Perc...
Condition
Pulmonary Nodule, Solitary
Enrollment
2,400 pts
Location
United States, Puerto Rico
Sponsor
Veracyte, Inc.
NCT06735014 N/A
Recruiting
Multicenter ALS Imaging Study
Condition
Amyotrophic Lateral Sclerosis
Enrollment
90 pts
Location
United States
Sponsor
University of Minnesota
NCT06975865 Phase 3
Recruiting
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years Wit...
Condition
Sickle Cell Disease
Enrollment
192 pts
Location
United States, Belgium, Brazil
Sponsor
Sanofi
NCT05484206 Phase 1
Recruiting
Effect of Hepatic Impairment on the Pharmacokinetics and Safety of VIR-2218 and ...
Condition
Hepatic Impairment
Enrollment
144 pts
Location
United States
Sponsor
Vir Biotechnology, Inc.
NCT06480552 Phase 1
Recruiting
An Open-label Dose Escalation/Expansion Trial to Evaluate the Safety and Anti-tu...
Condition
Advanced Solid Tumors
Enrollment
240 pts
Location
United States, Canada
Sponsor
Teva Branded Pharmaceutical Pr
NCT07577843 Phase 3
Recruiting
A Study of JNJ-78934804 in Participants With Moderately to Severely Active Crohn...
Condition
Crohn Disease
Enrollment
460 pts
Location
United States, Japan
Sponsor
Janssen Research & Development
NCT05184335 Phase 3
Recruiting
Safety and Efficacy of Brilaroxazine (RP5063) in Schizophrenia
Condition
Schizophrenia
Enrollment
690 pts
Location
United States
Sponsor
Reviva Pharmaceuticals
NCT06112418 N/A
Recruiting
A Randomized Comparison of Stage-Based Care Versus Risk Factor-Based Care for Pr...
Condition
Diabetes Mellitus, Type 2
Enrollment
7,500 pts
Location
United States
Sponsor
Cleerly, Inc.
NCT06297590 Phase 1
Recruiting
A First-In-Human Study of LY3954068 in Participants With Early Symptomatic Alzhe...
Condition
Alzheimer Disease
Enrollment
48 pts
Location
United States, Japan, United Kingdom
Sponsor
Eli Lilly and Company
NCT07009717 N/A
Recruiting
Relationship Between Great Toe Strength And Symptoms of Chemotherapy-Induced Per...
Condition
Chemotherapy-induced Peripheral Neuropathy (CIPN)
Enrollment
30 pts
Location
United States
Sponsor
University of Florida
NCT07174310 Phase 3
Recruiting
A Study to Evaluate the Efficacy and Safety of Intravenous (IV) Prasinezumab in ...
Condition
Parkinson's Disease
Enrollment
900 pts
Location
United States, Australia, Austria
Sponsor
Hoffmann-La Roche
NCT07218146 Phase 3
Recruiting
A Study of ZL-1310 Versus Investigator's Choice of Therapy in Participants With ...
Condition
Small-cell Lung Cancer
Enrollment
480 pts
Location
United States, China, Japan
Sponsor
Zai Lab (Shanghai) Co., Ltd.
NCT07284420 Phase 2
Recruiting
ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on Therapy ...
Condition
AChR-Ab Seropositive Generalized Myasthenia Gravis
Enrollment
70 pts
Location
United States, Belgium, Italy
Sponsor
argenx
NCT06297226 Phase 2
Recruiting
Study of Arlocabtagene Autoleucel (BMS-986393) a GPRC5D-directed CAR T Cell Ther...
Condition
Multiple Myeloma
Enrollment
230 pts
Location
United States, Australia, Canada
Sponsor
Juno Therapeutics, Inc., a Bri
NCT06941610 N/A
Recruiting
An Evaluation of the Erchonia Laser As a Non-Invasive Treatment to Improve the A...
Condition
Skin Laxity
Enrollment
35 pts
Location
United States
Sponsor
Erchonia Corporation
NCT04884035 Phase 1
Recruiting
Study of Safety and Efficacy of Iberdomide (CC-220) and CC-99282 Combined With R...
Condition
Lymphoma, B-Cell
Enrollment
224 pts
Location
United States, Australia, Greece
Sponsor
Celgene
NCT06001918 Phase 2, Phase 3
Recruiting
Nectero EAST System Clinical Study
Condition
Abdominal Aortic Aneurysm
Enrollment
400 pts
Location
United States, Australia, New Zealand
Sponsor
Nectero Medical, Inc.
NCT06745882 Phase 2
Recruiting
Prospective Trial Assessing Real World Outcomes Response to Pembro in Black Pati...
Condition
Non-small Cell Lung Cancer
Enrollment
318 pts
Location
United States
Sponsor
H. Lee Moffitt Cancer Center a
NCT07276724 Phase 3
Recruiting
A Study to Investigate GB-0895 Adjunctive Therapy in Adults and Adolescents With...
Condition
Severe Asthma
Enrollment
786 pts
Location
United States
Sponsor
Generate Biomedicines
NCT07265674 Phase 3
Recruiting
A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (P...
Condition
Advanced Biliary Tract Cancer
Enrollment
480 pts
Location
United States
Sponsor
J-Pharma Co., Ltd.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology